Literature DB >> 27959300

Cholestatic Liver Injury: Care of Patients With Primary Biliary Cholangitis or Primary Sclerosing Cholangitis.

Laurie Larson1, Michelle James1, Andrea Gossard1.   

Abstract

The most common causes of chronic cholestatic liver disease are primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC). Both disease processes are characterized by a destruction of intrahepatic and/or extrahepatic biliary ducts. The etiology is not entirely clear; however, there is an underlying autoimmune component contributing to both disease processes. Although PBC and PSC are often diagnosed and managed in the outpatient setting, in some instances, a patient may have jaundice, fatigue, and pruritus requiring evaluation and determination of the cholestatic cause. Patients with PSC should be monitored for evidence of cholangiocarcinoma, colon cancer, and gallbladder polyps as they are at an increased risk of malignant neoplasms. Liver transplant has the potential for improving quality of life, although disease recurrence is a risk. ©2016 American Association of Critical-Care Nurses.

Entities:  

Keywords:  Primary biliary cholangitis; cholangiocarcinoma; liver transplant; primary sclerosing cholangitis

Mesh:

Year:  2016        PMID: 27959300     DOI: 10.4037/aacnacc2016202

Source DB:  PubMed          Journal:  AACN Adv Crit Care        ISSN: 1559-7768


  2 in total

1.  Shenqi Fuzheng Injection impairs bile duct ligation-induced cholestatic liver injury in vivo.

Authors:  Fei Cao; Peng Liu; Xianbin Zhang; Yanfen Hu; Xin Dong; Haidong Bao; Lingkai Kong; Lei Wang; Peng Gong
Journal:  Biosci Rep       Date:  2019-01-25       Impact factor: 3.840

Review 2.  Mast Cells in Immune-Mediated Cholangitis and Cholangiocarcinoma.

Authors:  Marisol I González; Danielle T Vannan; Bertus Eksteen; Irán Flores-Sotelo; José Luis Reyes
Journal:  Cells       Date:  2022-01-22       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.